RPL28 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.469800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.564200E-01
Normal-vs-Stage2
9.537200E-01
Normal-vs-Stage3
9.886600E-01
Normal-vs-Stage4
6.354200E-01
Stage1-vs-Stage2
5.095800E-01
Stage1-vs-Stage3
7.256000E-01
Stage1-vs-Stage4
3.303200E-01
Stage2-vs-Stage3
9.716200E-01
Stage2-vs-Stage4
5.563800E-01
Stage3-vs-Stage4
6.019000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.620400E-01
Normal-vs-AfricanAmerican
7.949400E-01
Normal-vs-Asian
7.285600E-01
Caucasian-vs-AfricanAmerican
4.558000E-01
Caucasian-vs-Asian
5.071600E-01
AfricanAmerican-vs-Asian
3.051400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.832200E-01
Normal-vs-Female
7.547400E-01
Male-vs-Female
2.311900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.196400E-01
Normal-vs-Age(41-60Yrs)
8.984800E-01
Normal-vs-Age(61-80Yrs)
8.947800E-01
Normal-vs-Age(81-100Yrs)
5.157400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.127600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.307800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.765820E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.505970E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.241700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.301600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.849000E-01
Normal-vs-Daily Drinker
5.321600E-01
Normal-vs-Weekly Drinker
6.813200E-01
Normal-vs-Occasional Drinker
7.005400E-01
Normal-vs-Social Drinker
7.310600E-01
Non Drinker-vs-Daily Drinker
3.271900E-02
Non Drinker-vs-Weekly Drinker
2.474800E-01
Non Drinker-vs-Occasional Drinker
1.452800E-01
Non Drinker-vs-Social Drinker
3.379000E-01
Daily Drinker-vs-Weekly Drinker
9.255800E-01
Daily Drinker-vs-Occasional Drinker
4.208400E-01
Daily Drinker-vs-Social Drinker
6.176500E-03
Weekly Drinker-vs-Occasional Drinker
5.893000E-01
Weekly Drinker-vs-Social Drinker
1.358430E-01
Occasional Drinker-vs-Social Drinker
1.805510E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.244200E-01
Normal-vs-Grade 2
9.575200E-01
Normal-vs-Grade 3
9.632800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.266800E-01
Grade 1-vs-Grade 3
6.149400E-01
Grade 1-vs-Grade 4
9.244200E-01
Grade 2-vs-Grade 3
9.208600E-01
Grade 2-vs-Grade 4
9.575200E-01
Grade 3-vs-Grade 4
9.632800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.186400E-01
Normal-vs-NonDiabetic
8.823600E-01
Diabetic-vs-NonDiabetic
7.555000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.205200E-01
Normal-vs-NoPancreatitis
8.820200E-01
Pancreatitis-vs-NoPancreatitis
6.932600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.567800E-01
Normal-vs-N1
9.814200E-01
N0-vs-N1
2.261800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.543600E-01
Normal-vs-TP53-NonMutant
7.319400E-01
TP53-Mutant-vs-TP53-NonMutant
8.438400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
